Bottom line
Is OCSGX a good fund? The bottom line
OCSGX is a share class of Optimum Small-mid Cap Growth Fund, an actively managed small-cap mutual fund from Voya.
Its expense ratio is 2.19% — about $219 a year on every $10,000 invested, more expensive than 98% of small-cap funds we track.
It returned +7.4% over one year, +1.9% a year over five years, +10.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $947 million in net assets and 190 holdings, its largest position is Hinge Health Inc (1.6%) and the top 10 make up 13.8% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (2.19%)
- 5-year return in the bottom quarter of its category
- 12b-1 marketing fee of 1% a year
- High turnover (152% a year) can mean more taxable distributions
Updated Nov 19, 2026
What OCSGX invests in
Optimum Small-Mid Cap Growth Fund seeks long-term growth of capital.
Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities of small- and mid-market capitalization, growth-oriented companies (80% policy). This policy may be changed only upon 60 days prior notice to shareholders. For purposes of the Funds 80% policy , small-market capitalization companies are those companies whose market capitalization is similar to the market capitalization of companies in the Russell 2000 Growth Index, and mid-market capitalization companies are those companies whose market capitalization is similar to the market capitalization of companies in the Russell Midcap Growth Index. As of June 30, 2026 , the Russell 2000 Growth Index had a market capitalization range between approximately $ 157.7 million and $ 13.8 billion, and the Russell Midcap Growth Index had a market…
From the fund's prospectus (filed Jul 29, 2026).
OCSGX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| OCSGX | +7.4% | +1.9% | +10.1% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What OCSGX costs
On a $10,000 investment, OCSGX's 2.19% expense ratio costs about $219 a year. The prospectus estimates $2,627 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
OCSGX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Hinge Health Inc HNGE | 1.59% |
| 2 | Allegiant Travel Company ALGT | 1.55% |
| 3 | Idex Corp IEX | 1.52% |
| 4 | Applied Industrial Technologies Inc AIT | 1.36% |
| 5 | Littelfuse Inc LFUS | 1.34% |
| 6 | Wisdomtree Inc WT | 1.33% |
| 7 | Onto Innovation Inc ONTO | 1.32% |
| 8 | Cava Group Inc CAVA | 1.26% |
| 9 | Macom Technology Solutions Holdings Inc MTSI | 1.26% |
| 10 | Novanta Inc NOVT | 1.23% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 13.8% of the fund. See all top 25 holdings and asset mix →